METHODS: We conducted a phase 2 escalating dose study of a short course (7 days) of
intranasal OXT administration. We enrolled 18 infants with PWS under 6 months old (6 …

Prader–Willi syndrome (PWS) is a rare, complex multisystem genetic disorder which
includes hypothalamic dysfunction, hyperphagia, cognitive and behavioral problems …

Summary Background Prader–Willi syndrome (PWS) is known for hyperphagia with
impaired satiety and a specific behavioural phenotype with stubbornness, temper tantrums …

Abstract Context Prader‐Willi syndrome (PWS) is characterized by hypothalamic
dysfunction, hyperphagia and a typical behavioural phenotype, with characteristics of autism …

Objective The effects of intranasal oxytocin and placebo on hyperphagia and repetitive
behaviors were compared in children and adolescents with Prader Willi Syndrome (PWS) …

Prader–Willi syndrome (PWS) is a rare genetic disorder associated with distinct abnormal
behaviors including hyperphagia, profound social deficits, and obsessive‐compulsive …

Individuals with Prader–Willi syndrome (PWS) have a significant reduction in the number of
oxytocin‐producing neurons (42%) in the hypothalamic paraventricular nucleus. A number …

Abstract Background Prader-Willi syndrome (PWS) is a complex neurodevelopmental
genetic disorder with hypothalamic dysfunction, early morbid obesity with hyperphagia, and …

Summary Background Prader–Willi syndrome (PWS) is a neurogenetic disorder
characterized by muscular hypotonia, psychomotor delay, feeding difficulties and failure to …

Objective: Prader–Willi syndrome (PWS) is a genetic neurodevelopmental disorder with
several nutritional phases during childhood proceeding from poor feeding, through normal …